Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
2,487,812
-
Shares change
-
+507,573
-
Total reported value, excl. options
-
$52,101,000
-
Value change
-
+$10,712,473
-
Number of buys
-
7
-
Number of sells
-
-3
-
Price
-
$20.90
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q2 2018
14 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q2 2018.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,487,812 shares
.
Largest 10 shareholders include Parametric Portfolio Associates LLC (1,729,785 shares), GLENMEDE TRUST CO NA (368,960 shares), Pacer Advisors, Inc. (100,221 shares), NorthCoast Asset Management LLC (98,803 shares), FNY Investment Advisers, LLC (89,600 shares), World Asset Management Inc (47,391 shares), Pinnacle Wealth Planning Services, Inc. (29,217 shares), Kepos Capital LP (20,000 shares), QUADRANT CAPITAL GROUP LLC (1,509 shares), and Hexavest Inc. (1,134 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.